How a growth leader reads the monthly P&L pack
The first monthly pack I read properly, I read backwards. I went straight to the marketing spend line and the enquiry table, checked that the trend was in the right direction, and stopped. The unit’s yield per bed had fallen for three consecutive months on the page before. I had not turned to it, because nobody had told me it was mine.
The pack is the one document in a hospital group where growth decisions eventually show up as money. It is also written for finance, by finance, in an order that reflects how they think. If you read it in that order you will learn what happened. If you read it in the order growth needs, you will learn why — and, more usefully, what you did two quarters ago that caused it.
This is the reading order I now use, the questions I bring to the review, and — because I have sat across the table from the finance team often enough — the questions they wish growth would stop asking.
Start with occupancy and yield on the same page
Never read occupancy alone. Occupancy tells you how full the hospital was. Yield — revenue per occupied bed per day, or whatever your group’s version of it is — tells you what each full bed was worth. The two together tell you what kind of quarter it was, and each combination has a different growth story.
High occupancy with rising yield is the quarter everyone wants, and it is also the one to worry about, because it usually means a capacity constraint is coming. High occupancy with falling yield means the beds filled with the wrong mix or the wrong payer, and the growth engine has been buying volume rather than value. Low occupancy with high yield is a demand problem in a hospital that is otherwise working — the best problem to have, because marketing can actually fix it. Low occupancy with low yield is a unit in trouble, and no campaign will rescue it before the mix and pricing are fixed.
Read the pair for each unit, then read the trend for six months. One month tells you nothing. A three-month drift in yield with steady occupancy is the signature of a mix or discounting problem that started before anyone noticed.
Payer mix is the realisation behind the revenue
Revenue in the pack is booked at the tariff for the payer, not at the rack rate. The payer mix table is where you learn what your patients were actually worth.
Read the share of cash, insured through TPAs, corporate and government scheme, and read it against the same unit’s share six months ago. A shift towards schemes lifts occupancy and depresses yield; a shift towards cash does the reverse. Neither is inherently good. The question is whether the shift was chosen or happened to you, and the honest answer is usually the second.
Then read realisation by payer where finance provides it: the gap between what was billed and what was collected after disallowances. A payer whose realisation is falling is either becoming stricter on claims or has found problems in your documentation, and both of those are growth problems wearing operational clothes, because they determine whether the volume you brought in was worth bringing.
Specialty mix is where contribution lives
Most packs show revenue by specialty. Fewer show contribution by specialty, and the second is the one you need, because the difference between them is the entire growth argument.
A specialty can be the largest revenue line at a unit and the thinnest contributor, once consultant fees, implants, consumables and theatre time are taken out. Another can be a modest revenue line and a strong contributor because its cost structure is light. When you see which is which, you see whether the marketing money and the consultant hires of the last year went into the right places.
Where contribution by specialty is not in the pack, ask finance for it, and accept an approximate version. An allocation that is roughly right and available monthly is worth more than a precise one that arrives once a year. I spent the better part of a year waiting for the precise one. The approximate one, when I finally asked for it, took a fortnight and changed two budget decisions the same quarter.
OPD-to-IPD conversion is the number growth lives on
Every hospital fills its beds from its outpatient department first. The OPD-to-admission ratio, by specialty and by consultant, is the single number that most directly connects what growth brings in the door with what the P&L records.
Read it by specialty. A surgical specialty with strong OPD volume and weak conversion has a problem between the consultation and the admission — the estimate was too high, the wait was too long, the patient went to a competitor who quoted lower or admitted faster. A medical specialty with high conversion may be admitting patients who could have been day cases, which is a different problem and a payer-relations one.
Read it by consultant, carefully and privately. This is the number the medical director will already know and will not enjoy discussing in a room. The growth conversation is not about who converts poorly. It is about which consultants’ OPD is worth building demand for, because the demand you buy for a consultant who does not admit is wasted twice: once in the spend, and once in the patient who leaves with a poor impression of the hospital.
Receivables and discounting are the revenue you did not keep
Two lines in the pack tell you what happened to the revenue after it was earned. Receivables tell you what has not been collected. Discounts tell you what was given away before the bill was raised.
Read receivables by payer and by age. Scheme receivables that are lengthening are a government cash-flow problem you cannot fix, only anticipate. TPA receivables that are lengthening are usually a documentation or query problem, and that is fixable. Corporate receivables that lengthen are a relationship signal and worth a call before they become a write-off.
The discount line is the one I now read most closely, because it is the one that growth most directly causes and least often owns. Discounts granted at the front desk, discounts requested by consultants for their patients, discounts given to close a package negotiation, discounts labelled as goodwill after a complaint. Together they are a price cut nobody approved as a pricing decision. When the discount line rises alongside a demand campaign, the campaign brought in patients who were then sold at a lower price to keep them — and the growth number looks fine while the margin quietly does not.
The lines where growth decisions show up two quarters later
Very little of what a growth leader does lands in the month it happens. Learn the lags, so that you can read the pack as the record of your own decisions rather than as weather.
A consultant hired in a surgical specialty shows up in OPD volume within a month, in admissions within three, and in contribution within six — once the theatre list is established and the referrals have found him. A campaign in a specialty shows up in enquiries the same month, in OPD the next, in admissions the quarter after. A new TPA empanelment shows up in volume within a quarter and in receivables two quarters later, when the first claims have aged and the disallowances arrive. A price revision shows up in yield immediately and in conversion a month later, when the estimates have gone out and the patients have decided.
Keep a simple log of growth decisions by month — hires, campaigns, empanelments, price changes, discount policy changes — and read the pack against it. Most of what looks like noise in a unit’s numbers is the delayed arrival of something someone decided.
What to ask in the review
The review is where the pack becomes a decision. These are the questions that produce one.
- Where did yield move, and was it mix, payer or discount? Finance can usually decompose it if asked in advance.
- Which specialties are at capacity, and which have slack? The answer should change where next month’s demand money goes.
- Which consultants’ OPD conversion moved, and does the medical director know why?
- Which payer’s realisation or receivable days changed, and is there a documentation cause we can fix?
- What did the discount line cost this month, and who approved the largest items?
- Which of our decisions from two quarters ago should be showing up now, and are they?
- What would we stop funding if the capital queue tightened next month?
Send the questions before the meeting. A review where finance is asked to decompose yield on the spot produces a defensive answer. One where they had a week produces a useful one.
What finance wishes growth would stop asking
I have sat in enough budget reviews to have a list.
Stop asking for the attribution of every rupee of revenue to a marketing source. The pack cannot do it, the hospital information system cannot do it, and the request signals that you still think the revenue engine is a funnel. Ask instead which pool the volume came from and whether the mix was what we wanted.
Stop asking whether the marketing spend “is in the number”. It is in the cost line. The question you actually mean — did the spend produce contribution — is a different question, and it needs a model you and finance build together, not a footnote in the pack.
Stop asking for restatements. When a number in last month’s pack looks wrong to you, the answer is a conversation with the analyst who prepared it, not a request to reissue it. Finance defends every number that leaves the building, and a growth leader who forces reissues is teaching finance to show them less.
Stop asking for cuts of the data that do not exist yet. If you need contribution by specialty by payer, help build it. Do not ask for it monthly until it has been built once.
And stop treating the pack as an audit of marketing. It is an audit of the hospital. Read all of it. The finance team notices who does, and the ones who do are the ones who get shown the working.
If you’re starting this next quarter
- Get the last twelve packs for every unit and read them in the order above, not in the order they are printed.
- Build the decision log — hires, campaigns, empanelments, price and discount changes — going back at least two quarters, so that the next pack has something to be read against.
- Ask finance for three things you probably do not have: yield decomposition, contribution by specialty, and discounts by approver. Agree an approximate version for each and a date.
- Rewrite the growth section of the review as questions sent a week in advance. Keep it to seven.
- Sit with the analyst who prepares the pack for an hour. Learn where each number comes from and what it cannot tell you.
- Pick one unit and one lag — a consultant hire, a campaign, an empanelment — and trace it through six packs. Show the trace in the next review. That is how the room learns to think about growth as a delayed cause rather than a monthly result.
The pack does not tell you what marketing did. It tells you what the hospital did, and whether you had anything to do with it.
Questions people ask
The monthly P&L pack is the management report finance prepares for each unit — revenue, occupancy, yield, payer mix, specialty revenue, receivables and cost lines. It is the one document where growth decisions eventually show up as money. Read it in finance’s order and you learn what happened. Read it in the order growth needs and you learn why, and what you did two quarters ago that caused it.
Start with occupancy and yield on the same page, never occupancy alone. Then payer mix and realisation by payer. Then contribution by specialty, not just revenue. Then OPD-to-IPD conversion by specialty and consultant. Then receivables by payer and age, and the discount line. Finish with the marketing cost line, which is where most growth leaders start and stop.
Because each combination tells a different growth story. High occupancy with rising yield usually signals a capacity constraint coming. High occupancy with falling yield means the beds filled with the wrong mix or payer. Low occupancy with high yield is a demand problem marketing can fix. Low occupancy with low yield is a unit in trouble that no campaign rescues before mix and pricing are fixed. Read the pair over six months.
It tells you what your patients were actually worth, because revenue is booked at the payer’s tariff, not the rack rate. A shift toward government schemes lifts occupancy and depresses yield; a shift toward cash does the reverse. Neither is inherently good. The question is whether the shift was chosen or happened to you. Read realisation by payer too — falling realisation means stricter claims or documentation problems, both of which are growth problems in disguise.
Revenue is what was billed. Contribution is what remains after consultant fees, implants, consumables and theatre time come out. A specialty can be the largest revenue line and the thinnest contributor, while a modest specialty with a light cost structure contributes strongly. Contribution is where you see whether last year’s marketing money and consultant hires went to the right places. If the pack lacks it, ask finance for an approximate monthly version.
Because every hospital fills its beds from the outpatient department first, and the OPD-to-admission ratio is the most direct link between what growth brings in and what the P&L records. Read it by specialty to find leaks between consultation and admission — estimates too high, waits too long. Read it by consultant, privately, to decide whose OPD is worth building demand for. Demand bought for a consultant who does not admit is wasted twice.
Almost nothing lands in the month it happens. A surgical consultant hire shows in OPD within a month, admissions within three, contribution within six. A specialty campaign shows in enquiries the same month, OPD the next, admissions the quarter after. A new TPA empanelment shows in volume within a quarter and in receivables two quarters later. A price revision hits yield immediately and conversion a month later. Keep a decision log and read the pack against it.
Because it is the line growth most directly causes and least often owns. Front-desk discounts, consultant-requested discounts, package negotiations and goodwill after complaints add up to a price cut nobody approved as a pricing decision. When the discount line rises alongside a demand campaign, the campaign brought in patients who were then sold cheaper to keep them. The growth number looks fine while margin quietly erodes. Ask for discounts by approver.
Where did yield move, and was it mix, payer or discount? Which specialties are at capacity and which have slack? Which consultants’ OPD conversion moved, and does the medical director know why? Which payer’s realisation or receivable days changed, and is there a fixable documentation cause? What did discounts cost, and who approved the largest? Which decisions from two quarters ago should be showing now? Send these a week before the meeting, not in it.
Stop asking for attribution of every rupee of revenue to a marketing source — the pack and the hospital information system cannot do it. Stop asking whether marketing spend is in the number; it is in the cost line, and the real question needs a model built jointly. Stop demanding restatements; talk to the analyst instead. And stop asking monthly for data cuts that have never been built once. Finance shows the working to people who read all of it.
Fewer requests for attribution and more questions about mix, capacity and discounting. A growth leader who reads the pack properly arrives with a decision log — hires, campaigns, empanelments, price changes — and traces each one through subsequent packs. They ask for yield decomposition and contribution by specialty in approximate form, with a date, rather than waiting a year for a precise version. And they treat the pack as an audit of the hospital, not of marketing.
Read them by payer and by age. Lengthening scheme receivables are a government cash-flow issue you can only anticipate. Lengthening TPA receivables usually signal a documentation or query problem, which is fixable. Lengthening corporate receivables are a relationship warning worth a call before they become a write-off. Receivables tell you what happened to revenue after it was earned — and a payer channel that growth pushed hard will show its true cost here two quarters later.
It applies to both. In a single hospital the pack is shorter and the conversation is with one unit head and one finance lead, which makes it easier to get contribution by specialty and discounts by approver built. In a group, read the pair of occupancy and yield for every unit and compare trends across six months, because the same campaign or empanelment can be a good decision at one unit and a margin problem at another.
Get the last twelve packs for every unit and read them in the growth order, not the printed order. Build a decision log going back at least two quarters. Ask finance for yield decomposition, contribution by specialty and discounts by approver, agreeing an approximate version and a date for each. Sit with the analyst who prepares the pack for an hour. Then pick one unit and one lag, trace it through six packs, and show the trace in the next review.
